NCT04727151 2025-06-08
TACTIC-2
Triumvira Immunologics, Inc.
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT05165602 2021-12-21
Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System
Peking University
Unknown
NCT02378389 2015-03-04
Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown